Congress Incentivizes Rare Disease Research. Big Pharma Exploits It. – Mother Jones

Loopholes in the Orphan Drug Act serve drug companies, not patients.

Related Keywords

United States ,France ,Americans ,French ,Steven Pearson ,Eli Lilly ,Eric Sid ,Sneha Dave ,Scott Glovsky ,National Center ,Kaiser Health News ,Pearson ,Genentech ,Bespoke Gene Therapy Consortium ,Translational Sciences ,Institute For Clinical ,Us Congress ,National Institutes Of Health ,Orphan Drug Act ,Economic Review ,Jazz Pharmaceutical ,Jacobus Pharmaceutical ,Managed Care ,Inflation Reduction Act ,National Institutes ,Rare Disease Cures ,Advancing Translational Sciences ,Madeline Dean ,